NCT06614049
- Conditions
- Behavior, Dyslipidemias, Health Behavior, +10 more
- Locations
-
- National Healthcare Group Polyclinics Singapore
- National University Polyclinics Singapore
Clinical trial condition
Hyperlipidemia
Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.
343 public trials
22 recruiting studies
Hyperlipidemia trial results
NCT06503172
- Conditions
- Atrophy, Dyslipidemias, Frailty, +16 more
- Locations
-
- Taipei Veterans General hospital Taipei, Taiwan
Not yet recruiting
A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)
NCT07821944
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
- Locations
-
Not specified
Not yet recruiting
Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening
NCT07546162
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Not yet recruiting
Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors
NCT07117695
- Conditions
- ASCVD, Cardiovascular Diseases, Dyslipidemias, +7 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Not yet recruiting
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
NCT07799688
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- The First Affiliated Hospital of Shandong First Medical University (Qianfo Shan Hospital of shandong province). Jinan, Shandong, China
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
Not yet recruiting
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
NCT07730567
- Conditions
- Diabete Type 2, Diabetes Mellitus, Diabetes Mellitus, Type 2, +8 more
- Locations
-
- H+ Yangji Hospital, Seoul, Seoul, South Korea
Not yet recruiting
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
NCT07722299
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Not yet recruiting
Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals
NCT07712042
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Qianfoshan Hospital Ji'nan, China
Not yet recruiting
Management Strategy of 1L Lorlatinib With Hyperlipidemia in Stage IIIB-IV ALK Positive NSCLC
NCT07674524
- Conditions
- ALK Gene Mutation, ALK-positive, Bronchial Neoplasms, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China